Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,726 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Development of a new risk stratification system for patients with newly diagnosed multiple myeloma using R-ISS and 18F-FDG PET/CT.
Cho HJ, Jung SH, Jo JC, Lee YJ, Yoon SE, Park SS, Kim DY, Shin HJ, Mun YC, Yi JH, Kim HJ, Kim DJ, Lee HS, Bae SH, Hong CM, Jeong SY, Min JJ, Sohn SK, Min CK, Kim K, Lee JJ, Moon JH; Korean Multiple Myeloma Working Party. Cho HJ, et al. Among authors: kim hj, kim dy, kim dj, kim k. Blood Cancer J. 2021 Dec 1;11(12):190. doi: 10.1038/s41408-021-00577-2. Blood Cancer J. 2021. PMID: 34853295 Free PMC article.
A non-interventional, post-marketing surveillance study evaluating the safety and effectiveness of biosimilar rituximab (CT-P10) during routine clinical practice in the Republic of Korea.
Jo JC, Jeon Y, Kim D, Yang DH, Lee WS, Choi YS, Yi JH, Yoon DH, Kong JH, Choe JY, Kim S, Ahn K, Park T, Ju H, Kwon S, Cho SG. Jo JC, et al. Expert Opin Biol Ther. 2023 Jul-Dec;23(8):737-747. doi: 10.1080/14712598.2023.2177101. Epub 2023 Mar 8. Expert Opin Biol Ther. 2023. PMID: 36757373 Free article.
Incidence and risk factors of opportunistic infections after autologous stem cell transplantation: a nationwide, population-based cohort study in Korea.
Kim DJ, Jeong S, Kong SG, Lee S, Lim SN, Oh SY, Do YR, Lee WS, Lee MH, Bae SH, Kim SH, Kim MK, Lee HS; Consortium for Improving Survival of Lymphoma (CISL). Kim DJ, et al. Among authors: kim sh, kim mk. Sci Rep. 2023 Feb 13;13(1):2551. doi: 10.1038/s41598-023-27465-y. Sci Rep. 2023. PMID: 36781859 Free PMC article.
Open-labeled, multicenter phase II study of prophylactic administration of pegylated granulocyte colony-stimulating factor in relapsed or refractory multiple myeloma who received pomalidomide-based regimens (KMM170).
Song GY, Lee JJ, Moon JH, Kim D, Kim MK, Kim HJ, Mun YC, Lee WS, Do YR, Lee JH, Jung SH, Kim JS. Song GY, et al. Front Oncol. 2023 Oct 25;13:1209110. doi: 10.3389/fonc.2023.1209110. eCollection 2023. Front Oncol. 2023. PMID: 37965454 Free PMC article.
Nation-Wide Retrospective Analysis of Allogeneic Stem Cell Transplantation in Patients with Multiple Myeloma: A Study from Korean Multiple Myeloma Working Party (KMM1913).
Shin HJ, Kim DY, Kim K, Min CK, Lee JJ, Mun YC, Lee WS, Lim SN, Kim JS, Moon JH, Kim DJ, Bang SM, Won JH, Jo JC, Koh YI. Shin HJ, et al. Among authors: kim dy, kim dj, kim js, kim k. Cancer Res Treat. 2024 Jul;56(3):956-966. doi: 10.4143/crt.2024.074. Epub 2024 Mar 4. Cancer Res Treat. 2024. PMID: 38453275 Free PMC article.
Outcomes of acute kidney injury patients with and without cancer.
Juwon L, Jang G, Kim S, Kim D, Lee J, Park H, Lee J, Kim S, Kim Y, Kim SY, Yang JW, Gwoo S, Kim YN, Shin HS, Jung Y, Rim H. Juwon L, et al. Ren Fail. 2015 Nov;37(10):332-7. doi: 10.3109/0886022X.2015.1074489. Epub 2015 Oct 22. Ren Fail. 2015. PMID: 26493378 Free article.
3,726 results